Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.IVS30+3A>T (c.3838+3A>T) | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GAT | Asp | spl+3 | Spl. | A->T | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #17 | Ca2+ binding |
At the mRNA level | On restriction map |
Not tested on cDNA | New restriction site(s): none Lost restriction site(s): none |
Impact on splicing | ||||||||||
Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
TAGgtaagc |
| TAGgttagc |
| -8.4 % |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
AUS02WES F0022 I01 | Proband | NA | NA | <1 years old | AUSTRALIA |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
C-Asc. aortic dilatation |
C-Mitral valve prolapse |
S-Characteristic facial appearance |
S-Crowding teeth (m) |
S-High arched palate |
S-Joint hypermobility (m) |
Reference ID | PubMed ID | Reference |
114 | 14695540 | Biggin A, Holman K, Brett M, Bennetts B, Ades L. "Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy". Hum Mutat. 2004 Jan;23(1):99. |